Danaher | DHR - Marktkapitalisierung

Aktienkurs
167.04
Täglich Wechseln
3.18 1.94%
Monatlich
-14.56%
Jährlich
-15.54%
Q2 Prognose
158.66




Marktkapitalisierung Veränderung Datum
Abbott USD 178.41B 39.46B 2026-03
Agilent USD 37.86B 3.64B 2025-12
Align Technology USD 12.28B 1.07B 2026-03
Becton, Dickinson and Co. USD 44.45B 323M 2026-05
Bio Techne USD 7.45B 723M 2026-05
Boston Scientific USD 93.26B 48.09B 2026-03
Bruker USD 6.41B 915M 2026-05
Charles River Laboratories USD 9.29B 1.44B 2026-05
Danaher USD 128.46B 33.24B 2026-03
Dentsply International USD 2.28B 36M 2026-05
Edwards Lifesciences USD 46.17B 3.3B 2026-03
ESCO Technologies USD 7.73B 2.68B 2026-05
Fortive USD 17.26B 270M 2026-03
Henry Schein USD 8.95B 674M 2026-05
Illumina USD 17.88B 2.74B 2026-03
Intuitive Surgical USD 163.73B 37.04B 2026-03
IQVIA Holdings USD 31.35B 2.72B 2026-05
Keysight Technologies USD 58.08B 20.97B 2026-05
Laboratory Of America USD 21.93B 1.13B 2026-03
Mettler Toledo International USD 28.34B 2.8B 2026-05
Myriad Genetics USD 575M 98M 2025-12
OraSure Technologies USD 174M 61M 2025-12
Quest Diagnostics USD 21.69B 2.39B 2026-03
Quidel USD 780M 226M 2026-05
Repligen USD 7.01B 360M 2026-05
Revvity USD 11.4B 1.46B 2026-05
Roper Industries USD 36.23B 11.68B 2026-03
Stryker USD 125.85B 8.57B 2026-03
Thermo Fisher Scientific USD 182.66B 35.04B 2026-03
Waters USD 21.02B 8.84B 2026-05
Zimmer Biomet Holdings USD 17.5B 321M 2026-03